Task: Answer the multiple-choice question.
Query: Which drug exhibits a -3.025% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cc1ccccc1OCc1nnc(SCC(=O)Nc2ccc3c(c2)oc2ccccc23)n1C
(b) CCCOc1ccccc1/C=C1\SC(N)=NC1=O
(c) O=C(NCCC1=CCCCC1)c1ccc(CN2CCOCC2)cc1
(d) COCCn1c(=S)[nH]c2cc(C(=O)N3CC(C)CC(C)C3)ccc2c1=O
Answer: c. O=C(NCCC1=CCCCC1)c1ccc(CN2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCCC1=CCCCC1)c1ccc(CN2CCOCC2)cc1
O=C(NCCC1=CCCCC1)c1ccc(CN2CCOCC2)cc1
N-[2-(cyclohexen-1-yl)ethyl]-4-(morpholin-4-ylmethyl)benzamide